Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Leukemia
|
April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
J C Strefford, L-A Sutton, P Baliakas, et al.
Leukemia
|
May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia
E Chapiro, I Radford-Weiss, C Bastard, et al.
Leukemia
|
October 14, 2006
Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience
C Picard, S Hayette, C Bilhou-Nabera, et al.
Leukemia
|
December 13, 2003
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936
J J M van Dongen, A W Langerak, M Brüggemann, et al.
Leukemia
|
March 28, 2017
Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1
A Cosson, E Chapiro, N Bougacha, et al.
Leukemia
|
December 16, 2006
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936
M Brüggemann, H White, P Gaulard, et al.
Leukemia
|
August 25, 2012
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
A W Langerak, P J T A Groenen, M Brüggemann, et al.
Leukemia
|
December 16, 2006
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936
J H J M van Krieken, A W Langerak, E A Macintyre, et al.
Leukemia
|
December 16, 2006
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
P A S Evans, Ch Pott, P J T A Groenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2022
Molecular and clinical diversity in primary central nervous system lymphoma
I Hernández-Verdin, E Kirasic, K Wienand, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Leukemia
|
April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
J C Strefford, L-A Sutton, P Baliakas, et al.
Leukemia
|
May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia
E Chapiro, I Radford-Weiss, C Bastard, et al.
Leukemia
|
October 14, 2006
Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience
C Picard, S Hayette, C Bilhou-Nabera, et al.
Leukemia
|
December 13, 2003
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936
J J M van Dongen, A W Langerak, M Brüggemann, et al.
Leukemia
|
March 28, 2017
Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1
A Cosson, E Chapiro, N Bougacha, et al.
Leukemia
|
December 16, 2006
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936
M Brüggemann, H White, P Gaulard, et al.
Leukemia
|
August 25, 2012
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
A W Langerak, P J T A Groenen, M Brüggemann, et al.
Leukemia
|
December 16, 2006
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936
J H J M van Krieken, A W Langerak, E A Macintyre, et al.
Leukemia
|
December 16, 2006
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
P A S Evans, Ch Pott, P J T A Groenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2022
Molecular and clinical diversity in primary central nervous system lymphoma
I Hernández-Verdin, E Kirasic, K Wienand, et al.
Page
of 10